Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma

Local Institution, Copenhagen

Local Institution, Ghent

Memorial Sloan Kettering Cancer Center, New York

Local Institution, Marseille

University Of Pittsburgh Medical Center Cancer Center, Pittsburgh

Local Institution, Hamburg

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Local Institution, Leon, Guanajato

St. Jude Children'S Research Hospital, Memphis

Local Institution, Nantes

Local Institution, Dortmund

James Whitcomb Riley Hospital For Children, Indianapolis

Local Institution, M?nster

Local Institution, Münster

Mayo Clinic, Rochester

Local Institution, Lyon

The University Of Texas Md Anderson Cancer Center, Houston

Children'S Hospital Colorado, Aurora

Primary Children'S Medical Center, Salt Lake City

University Of Utah, Salt Lake City

Phoenix Children'S Hospital, Phoenix

Childrens Hospital Of La, Los Angeles

Local Institution, Erlangen

Children'S Hospital Of Orange County, Orange

Local Institution, Villejuif

Dana-Farber Cancer Institute, Boston

Local Institution, México

Local Institution, Df

Local Institution, Esplugues de Llobregat- Barcelona

Local Institution, Bristol

Local Institution, Newcastle

Local Institution, Sutton